Serum Alkaline Phosphatase and Mortality in African Americans with Chronic Kidney Disease
Open Access
- 1 November 2009
- journal article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 4 (11) , 1805-1810
Abstract
Background and objectives: Serum alkaline phosphatase has been associated with increased mortality in hemodialysis patients but its associations with mortality in chronic kidney disease (CKD) stages III and IV are unknown. Design, settings, participants & measurements: In 1094 participants in the African-American Study of Kidney Disease and Hypertension (AASK) database, the associations of serum alkaline phosphatase with mortality and cardiovascular events were examined in Cox models. Results: The mean (±SD) age was 54 ± 11 yr, and 61% were men. The median alkaline phosphatase was 80 IU/L, and interquartile range was 66 to 97 IU/L. The mean follow-up was 4.6 yr. There were 105 (9.6%) all-cause deaths and 149 (13.6%) cardiovascular events. Each doubling of serum alkaline phosphatase was significantly associated with increased hazard [hazard ratio (HR) 1.60, 95% confidence interval (CI) 1.08 −2.36] of all-cause mortality adjusted for demographics, drug and blood pressure groups, and comorbidity. With further adjustment for liver function tests as well as serum calcium and phosphorus, each doubling of serum alkaline phosphatase remained significantly associated with increased mortality (HR 1.55, 95% CI 1.03 to 2.33). Serum alkaline phosphatase was not significantly associated with increased risk of cardiovascular events. Conclusions: Independent of liver function tests and serum calcium and phosphorus, higher levels of serum alkaline phosphatase are associated with increased mortality in the CKD population. Further studies are warranted to identify the potential mechanisms for this association.Keywords
This publication has 14 references indexed in Scilit:
- Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markersNephrology Dialysis Transplantation, 2008
- High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and deathKidney International, 2008
- Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: Potential mechanism for uremic vascular calcificationKidney International, 2008
- Association between plasma alkaline phosphatase and C-reactive protein in Hong Kong ChineseClinical Chemistry and Laboratory Medicine (CCLM), 2008
- Novel Inhibitors of Alkaline Phosphatase Suppress Vascular Smooth Muscle Cell CalcificationJournal of Bone and Mineral Research, 2007
- Progressive Vascular Calcification over 2 Years Is Associated with Arterial Stiffening and Increased Mortality in Patients with Stages 4 and 5 Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2007
- The good and the bad in the link between insulin resistance and vascular calcificationAtherosclerosis, 2007
- Association Between Elevated Liver Enzymes and C-Reactive ProteinArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney DiseaseResults From the AASK TrialJAMA, 2002
- Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive NephrosclerosisA Randomized Controlled TrialJAMA, 2001